Navigation Links
PAREXEL to Present Leading Insights Regarding Key Industry Topics at 20th Annual Drug Information Association EuroMeeting
Date:2/25/2008

BOSTON, Feb. 25 /PRNewswire-FirstCall/ -- Experts from PAREXEL International Corporation (Nasdaq: PRXL), a leading global bio/pharmaceutical services provider, will present on key topics at the Drug Information Association's (DIA) 20th Annual EuroMeeting in Barcelona, Spain being held March 3 - 5, 2008. Attendees will benefit from presentations by some of PAREXEL's thought leaders, selected by the DIA to address industry issues including pharmacovigilance, globalization of clinical trials, data-driven patient recruitment, non-interventional studies, gene therapy regulations, combination products, biosimilars, and cosmeceuticals.

PAREXEL experts will present or chair the following sessions:

Monday, March 3

-- Pharmacovigilance and Medical Writing View With Emphasis on Practical

Solutions to the Pitfalls and Grey Areas (tutorial) - Alison Rapley,

Director, Medical Writing Services, Europe, Clinical Research Services

(9:00)

-- Navigating the Gene Therapy Regulations for Clinical Trials -- Cecil

Nick, Principal Consultant, PAREXEL Consulting

(11:00)

Tuesday, March 4

-- Globalization of Clinical Trials: Opportunities and Risks -- Session

Chair: Alberto Grignolo, Ph.D., Corporate Vice President and General

Manager, PAREXEL Consulting

(9:00)

-- Combination Products: Drug or Device? -- Cecil Nick, Principal

Consultant, PAREXEL Consulting

(9:00)

-- Data Driven Patient Recruitment: Tools for Early Planning and

Predictive Management (poster presentation) -- Petra Moll, Associate

Director, Clinical Operations, Clinical Research Services

Wednesday, March 5

-- Meeting Patient En
'/>"/>

SOURCE PAREXEL International Corporation
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related biology technology :

1. PAREXEL International to Present at Thomas Weisel Partners Healthcare Conference
2. Parexel Consulting Strengthens Good Manufacturing Practice Capabilities in Europe
3. PAREXEL International Completes Acquisition of APEX International Clinical Research Co., Ltd.
4. PAREXEL International Updates Financial Guidance in Conjunction with the Acquisition of APEX International Clinical Research Co., Ltd. and Other Factors
5. PAREXEL Announces Date of First Quarter Fiscal Year 2008 Earnings Release and Conference Call
6. PAREXEL Reports First Quarter Fiscal Year 2008 Financial Results
7. PAREXEL Appoints Charles A. Stevens as Vice President/General Manager of Health Policy and Strategic Reimbursement and Strengthens Capabilities
8. PAREXEL Announces Date of Second Quarter Fiscal Year 2008 Earnings Release and Conference Call
9. PAREXEL Names Biopharmaceutical Industry Executive Eduard E. Holdener to Board of Directors
10. PAREXEL Reports Second Quarter Fiscal Year 2008 Financial Results
11. PAREXEL International Announces 2-For-1 Stock Split
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/2/2015)... -- Research and Markets( http://www.researchandmarkets.com/research/7264hm/biomarkers ) has announced ... "Biomarkers - Technologies, Markets and Companies" to ... broad definition of a biomarker as a characteristic ... an indicator of normal biological or pathogenic processes ... intervention. Tests based on biomarkers have been around ...
(Date:6/2/2015)... --  Hospira, Inc. (NYSE: HSP ), a ... – a global biopharmaceutical company – has received approval ... Brazil – for Remsima (infliximab), ... Brazil . The medication will be ... infliximab in 26 European countries and in ...
(Date:6/2/2015)... Md. , June 2, 2015   ... leader in synthetic biology, announced today the appointment ... Senior Vice President, Consumer Sector.  Mr. Jarry will ... solutions in products and applications for consumer markets.  ... over 30 years of experience in leading global ...
(Date:6/2/2015)... June 2, 2015  Alere Inc. (NYSE: ... joined the White House Antibiotic Stewardship Forum today ... support and advance the President,s National Action Plan ... a number of measurable goals and objectives over ... help healthcare providers protect their patients through antibiotic ...
Breaking Biology Technology:Global Biomarkers Market Report 2015 - Technologies, Markets and Companies Analysis and Forecasts 2014-2024 2Global Biomarkers Market Report 2015 - Technologies, Markets and Companies Analysis and Forecasts 2014-2024 3ANVISA Approves First Infliximab Biosimilar in Brazil 2ANVISA Approves First Infliximab Biosimilar in Brazil 3ANVISA Approves First Infliximab Biosimilar in Brazil 4ANVISA Approves First Infliximab Biosimilar in Brazil 5Intrexon Announces New Sector Leader 2Intrexon Announces New Sector Leader 3Alere Announces Broad Initiatives to Help Combat Antibiotic Resistance during White House Antibiotic Stewardship Forum 2
... Syngenta and DuPont today announced that Syngenta has ... 8, 2010. The transaction dissolves a joint venture between ... enables Syngenta and Pioneer to pursue independent licensing strategies ... biotechnology traits. Davor Pisk, Chief Operating ...
... 9, 2010 Reportlinker.com announces that a new market ... Biomarkers - technologies,markets and companies ... This report follows the broad definition ... objectively measured and evaluated as an indicator of normal ...
... 2010 Cardium Therapeutics (NYSE Amex: CXM ... third quarter ended September 30, 2010.  Highlights of the ... market launch of Cardium,s MedPodium product line, a portfolio ... nutraceuticals and aesthetics designed to promote and manage personal ...
Cached Biology Technology:Syngenta and DuPont Announce Ownership Change at GreenLeaf Genetics 2Syngenta and DuPont Announce Ownership Change at GreenLeaf Genetics 3Syngenta and DuPont Announce Ownership Change at GreenLeaf Genetics 4Reportlinker Adds Biomarkers - Technologies, Markets And Companies 2Reportlinker Adds Biomarkers - Technologies, Markets And Companies 3Reportlinker Adds Biomarkers - Technologies, Markets And Companies 4Reportlinker Adds Biomarkers - Technologies, Markets And Companies 5Reportlinker Adds Biomarkers - Technologies, Markets And Companies 6Reportlinker Adds Biomarkers - Technologies, Markets And Companies 7Reportlinker Adds Biomarkers - Technologies, Markets And Companies 8Reportlinker Adds Biomarkers - Technologies, Markets And Companies 9Reportlinker Adds Biomarkers - Technologies, Markets And Companies 10Reportlinker Adds Biomarkers - Technologies, Markets And Companies 11Reportlinker Adds Biomarkers - Technologies, Markets And Companies 12Reportlinker Adds Biomarkers - Technologies, Markets And Companies 13Reportlinker Adds Biomarkers - Technologies, Markets And Companies 14Reportlinker Adds Biomarkers - Technologies, Markets And Companies 15Reportlinker Adds Biomarkers - Technologies, Markets And Companies 16Reportlinker Adds Biomarkers - Technologies, Markets And Companies 17Reportlinker Adds Biomarkers - Technologies, Markets And Companies 18Reportlinker Adds Biomarkers - Technologies, Markets And Companies 19Reportlinker Adds Biomarkers - Technologies, Markets And Companies 20Cardium Reports on Third Quarter 2010 Financial Results and Recent Developments 2Cardium Reports on Third Quarter 2010 Financial Results and Recent Developments 3Cardium Reports on Third Quarter 2010 Financial Results and Recent Developments 4Cardium Reports on Third Quarter 2010 Financial Results and Recent Developments 5Cardium Reports on Third Quarter 2010 Financial Results and Recent Developments 6Cardium Reports on Third Quarter 2010 Financial Results and Recent Developments 7Cardium Reports on Third Quarter 2010 Financial Results and Recent Developments 8Cardium Reports on Third Quarter 2010 Financial Results and Recent Developments 9
(Date:4/20/2015)... The announcement comes as demand ... Management (GRM), Ireland,s foremost records management ... built up an impressive track record of clients within the ... the records management sector in Dubai . ... staffbase and employ a further eight staff members at its ...
(Date:4/14/2015)... 2015  HYPR Corp. today announced it has ... Alliance tm , an industry consortium transforming online ... share technology and collaborate to deliver open specifications ... secure and private, and easier to use. ... protects sensitive user information and eliminates the dependency ...
(Date:4/13/2015)... April 13, 2015 According ... "Global Biometrics Market Forecast & Opportunities, 2020", the global ... of around 14% till 2020. The biometrics market ... scale implementation and review of biometric management systems. ... new products with greater efficiency, are resulting in ...
Breaking Biology News(10 mins):Glenbeigh Records Management Wins Contract With Dubai Islamic Bank 2Glenbeigh Records Management Wins Contract With Dubai Islamic Bank 3HYPR Corp. Joins the FIDO Alliance 2HYPR Corp. Joins the FIDO Alliance 3Global Biometrics Market to Cross US$ 21 Billion by 2020: TechSci Research 2
... Scientists have found that a large proportion of infants ... disease. The disease is the most prevalent acute wheezing ... admission to hospital in the first year of life in ... admitted to hospital for bronchiolitis - needing oxygen and help ...
... from small rings of naturally occurring plant DNA can ... embryonic plants where they are expressed, duplicated as plant ... -- a long-term goal for those interested in improving ... issue of PLoS-Genetics, a team of academic and commercial ...
... Research Hospital have identified the cell that gives rise to ... growth and development. The finding suggests for the first time ... induce fully developed neurons to multiply and coax the injured ... work appears in the Oct. 19 issue of the journal ...
Cached Biology News:Scientists find predisposition to bronchiolitis in some babies 2Transgenics transformed 2Transgenics transformed 3St. Jude identifies the specific cell that causes eye cancer, disproving long-held theory 2St. Jude identifies the specific cell that causes eye cancer, disproving long-held theory 3
... is a new product number, ... product number. If showing no ... the old Sigma-Aldrich number (C6921) ... assistance. Mfr Desig: Corning ...
A cost-effective serum for general cell growth requirements. All serum is collected from calves aged 10 days old or less....
... This CLS number is ... to easily match Cornings product ... yet, please order under the ... contact customer service for assistance. ...
... culture scale-up, these culture chambers produce cell ... 9 range and are useful alternatives ... • High mechanical • strength and structural ... shipping • Certified nonpyrogenic and sterilized by ...
Biology Products: